TRAW
TRAW
NASDAQ · Pharmaceuticals

Traws Pharma Inc

$0.53
-0.01 (-1.30%)
As of Aug 8, 2:28 AM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +4,080.5% upside
Low Target $15.33
Average Target $22.24
High Target $34.90
Current Price $0.53
Current
$0.53
Target
$22.24
$15.33 $22.24 avg $34.90
Scenario Analysis
Bear Case
$15.33
2,781.6%
Low target
Base Case
$22.24
+4,080.5%
Avg target
Bull Case
$34.90
+6,460.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.27
-83.7% from high
52-Week Low
$0.43
+23.7% from low
Target vs 52W High
$22.24
+581.2% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.34
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%